(Sea instructions): Project 2: Late Stage Lung Cancer focuses on Stages Illb-IV unresectable lung cancer within a program project with central themes related to palliative care, quality of life (QOL), and symptom management. This project focuses on Late Stage Lung Cancer, a population who have decreased survival and high QOL and symptom concerns.
The aims of the research are:
Aim1 : Test the effects of the Palliative Care Intervention (PCI) on overall QOL and psychological distress for patients with Late (Stage Illb-IV) non-resectable NSCLC compared to a group receiving usual care.
Aim 2 : Compare symptom control in the PCI group versus the usual care group in Late Stage NSCLC.
Aim 3 : Compare geriatric assessment outcomes (OARS Instrumental Activities of Daily Living, MOS Activities of Daily Living, MOS Social Activities Limitation Scale, Hospital Anxiety and Depression Scale scores, and the Karnofsky Performance Scale) in the PCI group versus the usual care group.
Aim 4 : Test the effects of the PCI on resource use as compared to the usual care group.
Aim 5 : Identify subgroups of patients who benefit most from the PCI in relation to sociodemographic characteristics, treatment factors, and geriatric assessment predictors at the 12 week primary end point. A two-group, prospective sequential, quasi-experimental, tandem enrollment design (N=326) will be used for this project, in which the usual care group is accrued and followed during Phase 1 and the intervention group is accrued and followed during Phase 2. The proposed PCI intervention combines pre-treatment assessment and goal setting through the collaboration of an interdisciplinary team. The Palliative Care Intervention is based on pilot work completed from 2005-2007 by the investigators documenting needs of lung cancer patients and testing the intervention. This project has great significance to public health given the significant numbers of people diagnosed with lung cancer and the associated individual and societal costs.

Public Health Relevance

Lung cancer impacts elderly patients, creates extensive family and social burden and both psychosocial and financial consequences are substantial. Integration of palliative care into late stage lung cancer care can serve as a public health model to maximize both quality of life and health care resources.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-GRB-P)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
City of Hope/Beckman Research Institute
United States
Zip Code
Fujinami, Rebecca; Sun, Virginia; Zachariah, Finly et al. (2015) Family caregivers' distress levels related to quality of life, burden, and preparedness. Psychooncology 24:54-62
Kernstine, Kemp H; Moon, James; Kraut, Michael J et al. (2014) Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup Trial S0220. Ann Thorac Surg 98:402-10
Otis-Green, Shirley; Sidhu, Rupinder K; Del Ferraro, Catherine et al. (2014) Integrating social work into palliative care for lung cancer patients and families: a multidimensional approach. J Psychosoc Oncol 32:431-46
Koczywas, Marianna; Cristea, Mihaela; Thomas, Jay et al. (2013) Interdisciplinary palliative care intervention in metastatic non-small-cell lung cancer. Clin Lung Cancer 14:736-44
Koczywas, Marianna; Williams, Anna Cathy; Cristea, Mihaela et al. (2013) Longitudinal changes in function, symptom burden, and quality of life in patients with early-stage lung cancer. Ann Surg Oncol 20:1788-97
Grant, Marcia; Sun, Virginia; Fujinami, Rebecca et al. (2013) Family caregiver burden, skills preparedness, and quality of life in non-small cell lung cancer. Oncol Nurs Forum 40:337-46
Borneman, Tami; Bluman, Olga F; Klein, Linda et al. (2013) Spiritual care for Jewish patients facing a life-threatening illness. J Palliat Care 29:58-62
Ferrell, Betty; Koczywas, Marianna; Grannis, Fred et al. (2011) Palliative care in lung cancer. Surg Clin North Am 91:403-17, ix